Merck Stock Forecast
NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:03 PM ET · Delayed 15 min
MRK analyst consensus
Consensus (27 analysts)
buy
Avg. price target
$156.28+9.76%
- Strong buy 5
- Buy 14
- Hold 8
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 27 Wall Street analysts covering Merck (2026-10-07), 19 rate the stock a buy or strong buy, 8 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $156.28, with a high estimate of $186.00 and a low estimate of $105.00. The average target implies upside of 9.8% from the current price of $142.38.
The spread between the highest and lowest targets is 77.1%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for MRK.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 19% |
| Buy | 14 | 52% |
| Hold | 8 | 30% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $105.00 | -26.25% |
| Average target | $156.28 | +9.76% |
| High target | $186.00 | +30.64% |